ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-25F17292
Home | Market Reports | Health| Reproductive Health
Global Non invasive Prenatal Paternity Testing NIPPT Market Research Report 2024
BUY CHAPTERS

Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-25F17292
Report
October 2025
Pages:177
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Express Diagnostic Center (EDC)
AlphaBiolabs Ltd
Natera
Illumina Inc
BGI Genomics
Roche Company
LabCorp
DDC
International Biosciences
Axis DNA Labs
AffinityDNA
Ultrasound Plus
PrenatalGeneticslab
Acecgt Group
EasyDNA
DNAQ
Choice DNA
DNA Forensics Laboratory
Brooklyn DNA Testing
SmarTest Labs
Fastest Labs
Validity Genetics
Suspire LLC
Carlson Company
PTC Laboratories
My Forever DNA
Dynacare
Vgenes Inc

Non-invasive Prenatal Paternity Testing(NIPPT) Market

The global Non-invasive Prenatal Paternity Testing(NIPPT) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Non-invasive Prenatal Paternity Testing (NIPPT) is a method used to establish paternity before a child is born without the need for invasive procedures, such as amniocentesis or chorionic villus sampling. It relies on analyzing cell-free fetal DNA present in the mother's blood to determine the biological relationship between the alleged father and the unborn child.
From a downstream perspective, Non-legal Paternity Test accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Non-invasive Prenatal Paternity Testing(NIPPT) leading manufacturers including Express Diagnostic Center (EDC), AlphaBiolabs, Natera, Illumina, BGI Genomics, Roche company, LabCorp, DDC, International Biosciences, Axis DNA Labs, etc., dominate supply; the top five capture approximately % of global revenue, with Express Diagnostic Center (EDC) leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Non-invasive Prenatal Paternity Testing(NIPPT) market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Non-invasive Prenatal Paternity Testing(NIPPT) Market Report

Report Metric Details
Report Name Non-invasive Prenatal Paternity Testing(NIPPT) Market
Segment by Type
Segment by Application
  • Non-legal Paternity Test
  • Legal Paternity Test
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Express Diagnostic Center (EDC), AlphaBiolabs, Natera, Illumina, BGI Genomics, Roche company, LabCorp, DDC, International Biosciences, Axis DNA Labs, AffinityDNA, Ultrasound Plus, PrenatalGeneticslab, Acecgt Group, EasyDNA, DNAQ, Choice DNA, DNA Forensics Laboratory, Brooklyn DNA Testing, SmarTest Labs, Fastest Labs, Validity Genetics, Suspire LLC, Carlson Company, PTC Laboratories, My Forever DNA, Dynacare, Vgenes Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Non-invasive Prenatal Paternity Testing(NIPPT) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Non-invasive Prenatal Paternity Testing(NIPPT) Market report?

Ans: The main players in the Non-invasive Prenatal Paternity Testing(NIPPT) Market are Express Diagnostic Center (EDC), AlphaBiolabs, Natera, Illumina, BGI Genomics, Roche company, LabCorp, DDC, International Biosciences, Axis DNA Labs, AffinityDNA, Ultrasound Plus, PrenatalGeneticslab, Acecgt Group, EasyDNA, DNAQ, Choice DNA, DNA Forensics Laboratory, Brooklyn DNA Testing, SmarTest Labs, Fastest Labs, Validity Genetics, Suspire LLC, Carlson Company, PTC Laboratories, My Forever DNA, Dynacare, Vgenes Inc

What are the Application segmentation covered in the Non-invasive Prenatal Paternity Testing(NIPPT) Market report?

Ans: The Applications covered in the Non-invasive Prenatal Paternity Testing(NIPPT) Market report are Non-legal Paternity Test, Legal Paternity Test

What are the Type segmentation covered in the Non-invasive Prenatal Paternity Testing(NIPPT) Market report?

Ans: The Types covered in the Non-invasive Prenatal Paternity Testing(NIPPT) Market report are Service, Reagents

Recommended Reports

Paternity & Prenatal Testing

Non-invasive Diagnostics

Genetic & Fertility Testing

1 Study Coverage
1.1 Introduction to Non-invasive Prenatal Paternity Testing(NIPPT): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Service
1.2.3 Reagents
1.3 Market Segmentation by Application
1.3.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Non-legal Paternity Test
1.3.3 Legal Paternity Test
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Estimates and Forecasts 2020-2031
2.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Service Market Size by Players
3.3.2 Reagents Market Size by Players
3.4 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Type (2020-2031)
6.4 North America Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Type (2020-2031)
7.4 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Type (2020-2031)
8.4 Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Type (2020-2031)
9.4 Central and South America Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Type (2020-2031)
10.4 Middle East and Africa Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Express Diagnostic Center (EDC)
11.1.1 Express Diagnostic Center (EDC) Corporation Information
11.1.2 Express Diagnostic Center (EDC) Business Overview
11.1.3 Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.1.4 Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.1.5 Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Product in 2024
11.1.6 Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application in 2024
11.1.7 Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Geographic Area in 2024
11.1.8 Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) SWOT Analysis
11.1.9 Express Diagnostic Center (EDC) Recent Developments
11.2 AlphaBiolabs
11.2.1 AlphaBiolabs Corporation Information
11.2.2 AlphaBiolabs Business Overview
11.2.3 AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.2.4 AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.2.5 AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Product in 2024
11.2.6 AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application in 2024
11.2.7 AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Geographic Area in 2024
11.2.8 AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) SWOT Analysis
11.2.9 AlphaBiolabs Recent Developments
11.3 Natera
11.3.1 Natera Corporation Information
11.3.2 Natera Business Overview
11.3.3 Natera Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.3.4 Natera Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.3.5 Natera Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Product in 2024
11.3.6 Natera Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application in 2024
11.3.7 Natera Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Geographic Area in 2024
11.3.8 Natera Non-invasive Prenatal Paternity Testing(NIPPT) SWOT Analysis
11.3.9 Natera Recent Developments
11.4 Illumina
11.4.1 Illumina Corporation Information
11.4.2 Illumina Business Overview
11.4.3 Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.4.4 Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.4.5 Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Product in 2024
11.4.6 Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application in 2024
11.4.7 Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Geographic Area in 2024
11.4.8 Illumina Non-invasive Prenatal Paternity Testing(NIPPT) SWOT Analysis
11.4.9 Illumina Recent Developments
11.5 BGI Genomics
11.5.1 BGI Genomics Corporation Information
11.5.2 BGI Genomics Business Overview
11.5.3 BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.5.4 BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.5.5 BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Product in 2024
11.5.6 BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application in 2024
11.5.7 BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Geographic Area in 2024
11.5.8 BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) SWOT Analysis
11.5.9 BGI Genomics Recent Developments
11.6 Roche company
11.6.1 Roche company Corporation Information
11.6.2 Roche company Business Overview
11.6.3 Roche company Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.6.4 Roche company Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.6.5 Roche company Recent Developments
11.7 LabCorp
11.7.1 LabCorp Corporation Information
11.7.2 LabCorp Business Overview
11.7.3 LabCorp Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.7.4 LabCorp Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.7.5 LabCorp Recent Developments
11.8 DDC
11.8.1 DDC Corporation Information
11.8.2 DDC Business Overview
11.8.3 DDC Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.8.4 DDC Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.8.5 DDC Recent Developments
11.9 International Biosciences
11.9.1 International Biosciences Corporation Information
11.9.2 International Biosciences Business Overview
11.9.3 International Biosciences Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.9.4 International Biosciences Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.9.5 International Biosciences Recent Developments
11.10 Axis DNA Labs
11.10.1 Axis DNA Labs Corporation Information
11.10.2 Axis DNA Labs Business Overview
11.10.3 Axis DNA Labs Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.10.4 Axis DNA Labs Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 AffinityDNA
11.11.1 AffinityDNA Corporation Information
11.11.2 AffinityDNA Business Overview
11.11.3 AffinityDNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.11.4 AffinityDNA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.11.5 AffinityDNA Recent Developments
11.12 Ultrasound Plus
11.12.1 Ultrasound Plus Corporation Information
11.12.2 Ultrasound Plus Business Overview
11.12.3 Ultrasound Plus Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.12.4 Ultrasound Plus Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.12.5 Ultrasound Plus Recent Developments
11.13 PrenatalGeneticslab
11.13.1 PrenatalGeneticslab Corporation Information
11.13.2 PrenatalGeneticslab Business Overview
11.13.3 PrenatalGeneticslab Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.13.4 PrenatalGeneticslab Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.13.5 PrenatalGeneticslab Recent Developments
11.14 Acecgt Group
11.14.1 Acecgt Group Corporation Information
11.14.2 Acecgt Group Business Overview
11.14.3 Acecgt Group Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.14.4 Acecgt Group Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.14.5 Acecgt Group Recent Developments
11.15 EasyDNA
11.15.1 EasyDNA Corporation Information
11.15.2 EasyDNA Business Overview
11.15.3 EasyDNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.15.4 EasyDNA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.15.5 EasyDNA Recent Developments
11.16 DNAQ
11.16.1 DNAQ Corporation Information
11.16.2 DNAQ Business Overview
11.16.3 DNAQ Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.16.4 DNAQ Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.16.5 DNAQ Recent Developments
11.17 Choice DNA
11.17.1 Choice DNA Corporation Information
11.17.2 Choice DNA Business Overview
11.17.3 Choice DNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.17.4 Choice DNA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.17.5 Choice DNA Recent Developments
11.18 DNA Forensics Laboratory
11.18.1 DNA Forensics Laboratory Corporation Information
11.18.2 DNA Forensics Laboratory Business Overview
11.18.3 DNA Forensics Laboratory Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.18.4 DNA Forensics Laboratory Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.18.5 DNA Forensics Laboratory Recent Developments
11.19 Brooklyn DNA Testing
11.19.1 Brooklyn DNA Testing Corporation Information
11.19.2 Brooklyn DNA Testing Business Overview
11.19.3 Brooklyn DNA Testing Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.19.4 Brooklyn DNA Testing Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.19.5 Brooklyn DNA Testing Recent Developments
11.20 SmarTest Labs
11.20.1 SmarTest Labs Corporation Information
11.20.2 SmarTest Labs Business Overview
11.20.3 SmarTest Labs Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.20.4 SmarTest Labs Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.20.5 SmarTest Labs Recent Developments
11.21 Fastest Labs
11.21.1 Fastest Labs Corporation Information
11.21.2 Fastest Labs Business Overview
11.21.3 Fastest Labs Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.21.4 Fastest Labs Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.21.5 Fastest Labs Recent Developments
11.22 Validity Genetics
11.22.1 Validity Genetics Corporation Information
11.22.2 Validity Genetics Business Overview
11.22.3 Validity Genetics Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.22.4 Validity Genetics Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.22.5 Validity Genetics Recent Developments
11.23 Suspire LLC
11.23.1 Suspire LLC Corporation Information
11.23.2 Suspire LLC Business Overview
11.23.3 Suspire LLC Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.23.4 Suspire LLC Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.23.5 Suspire LLC Recent Developments
11.24 Carlson Company
11.24.1 Carlson Company Corporation Information
11.24.2 Carlson Company Business Overview
11.24.3 Carlson Company Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.24.4 Carlson Company Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.24.5 Carlson Company Recent Developments
11.25 PTC Laboratories
11.25.1 PTC Laboratories Corporation Information
11.25.2 PTC Laboratories Business Overview
11.25.3 PTC Laboratories Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.25.4 PTC Laboratories Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.25.5 PTC Laboratories Recent Developments
11.26 My Forever DNA
11.26.1 My Forever DNA Corporation Information
11.26.2 My Forever DNA Business Overview
11.26.3 My Forever DNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.26.4 My Forever DNA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.26.5 My Forever DNA Recent Developments
11.27 Dynacare
11.27.1 Dynacare Corporation Information
11.27.2 Dynacare Business Overview
11.27.3 Dynacare Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.27.4 Dynacare Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.27.5 Dynacare Recent Developments
11.28 Vgenes Inc
11.28.1 Vgenes Inc Corporation Information
11.28.2 Vgenes Inc Business Overview
11.28.3 Vgenes Inc Non-invasive Prenatal Paternity Testing(NIPPT) Product Features and Attributes
11.28.4 Vgenes Inc Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2020-2025)
11.28.5 Vgenes Inc Recent Developments
12 Non-invasive Prenatal Paternity Testing(NIPPT)Industry Chain Analysis
12.1 Non-invasive Prenatal Paternity Testing(NIPPT) Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Non-invasive Prenatal Paternity Testing(NIPPT) Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Non-invasive Prenatal Paternity Testing(NIPPT) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Express Diagnostic Center (EDC)
AlphaBiolabs Ltd
Natera
Illumina Inc
BGI Genomics
Roche Company
LabCorp
DDC
International Biosciences
Axis DNA Labs
AffinityDNA
Ultrasound Plus
PrenatalGeneticslab
Acecgt Group
EasyDNA
DNAQ
Choice DNA
DNA Forensics Laboratory
Brooklyn DNA Testing
SmarTest Labs
Fastest Labs
Validity Genetics
Suspire LLC
Carlson Company
PTC Laboratories
My Forever DNA
Dynacare
Vgenes Inc
List of Tables
 Table 1. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Non-invasive Prenatal Paternity Testing(NIPPT) by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Prenatal Paternity Testing(NIPPT) as of 2024)
 Table 11. Global Non-invasive Prenatal Paternity Testing(NIPPT) Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Non-invasive Prenatal Paternity Testing(NIPPT) Companies Headquarters
 Table 13. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Non-invasive Prenatal Paternity Testing(NIPPT) High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Non-invasive Prenatal Paternity Testing(NIPPT) Growth Accelerators and Market Barriers
 Table 25. North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Growth Accelerators and Market Barriers
 Table 27. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Non-invasive Prenatal Paternity Testing(NIPPT) Investment Opportunities and Key Challenges
 Table 31. Central and South America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Non-invasive Prenatal Paternity Testing(NIPPT) Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Express Diagnostic Center (EDC) Corporation Information
 Table 35. Express Diagnostic Center (EDC) Description and Major Businesses
 Table 36. Express Diagnostic Center (EDC) Product Features and Attributes
 Table 37. Express Diagnostic Center (EDC) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Express Diagnostic Center (EDC) Revenue Proportion by Product in 2024
 Table 39. Express Diagnostic Center (EDC) Revenue Proportion by Application in 2024
 Table 40. Express Diagnostic Center (EDC) Revenue Proportion by Geographic Area in 2024
 Table 41. Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) SWOT Analysis
 Table 42. Express Diagnostic Center (EDC) Recent Developments
 Table 43. AlphaBiolabs Corporation Information
 Table 44. AlphaBiolabs Description and Major Businesses
 Table 45. AlphaBiolabs Product Features and Attributes
 Table 46. AlphaBiolabs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. AlphaBiolabs Revenue Proportion by Product in 2024
 Table 48. AlphaBiolabs Revenue Proportion by Application in 2024
 Table 49. AlphaBiolabs Revenue Proportion by Geographic Area in 2024
 Table 50. AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) SWOT Analysis
 Table 51. AlphaBiolabs Recent Developments
 Table 52. Natera Corporation Information
 Table 53. Natera Description and Major Businesses
 Table 54. Natera Product Features and Attributes
 Table 55. Natera Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Natera Revenue Proportion by Product in 2024
 Table 57. Natera Revenue Proportion by Application in 2024
 Table 58. Natera Revenue Proportion by Geographic Area in 2024
 Table 59. Natera Non-invasive Prenatal Paternity Testing(NIPPT) SWOT Analysis
 Table 60. Natera Recent Developments
 Table 61. Illumina Corporation Information
 Table 62. Illumina Description and Major Businesses
 Table 63. Illumina Product Features and Attributes
 Table 64. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Illumina Revenue Proportion by Product in 2024
 Table 66. Illumina Revenue Proportion by Application in 2024
 Table 67. Illumina Revenue Proportion by Geographic Area in 2024
 Table 68. Illumina Non-invasive Prenatal Paternity Testing(NIPPT) SWOT Analysis
 Table 69. Illumina Recent Developments
 Table 70. BGI Genomics Corporation Information
 Table 71. BGI Genomics Description and Major Businesses
 Table 72. BGI Genomics Product Features and Attributes
 Table 73. BGI Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. BGI Genomics Revenue Proportion by Product in 2024
 Table 75. BGI Genomics Revenue Proportion by Application in 2024
 Table 76. BGI Genomics Revenue Proportion by Geographic Area in 2024
 Table 77. BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) SWOT Analysis
 Table 78. BGI Genomics Recent Developments
 Table 79. Roche company Corporation Information
 Table 80. Roche company Description and Major Businesses
 Table 81. Roche company Product Features and Attributes
 Table 82. Roche company Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Roche company Recent Developments
 Table 84. LabCorp Corporation Information
 Table 85. LabCorp Description and Major Businesses
 Table 86. LabCorp Product Features and Attributes
 Table 87. LabCorp Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. LabCorp Recent Developments
 Table 89. DDC Corporation Information
 Table 90. DDC Description and Major Businesses
 Table 91. DDC Product Features and Attributes
 Table 92. DDC Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. DDC Recent Developments
 Table 94. International Biosciences Corporation Information
 Table 95. International Biosciences Description and Major Businesses
 Table 96. International Biosciences Product Features and Attributes
 Table 97. International Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. International Biosciences Recent Developments
 Table 99. Axis DNA Labs Corporation Information
 Table 100. Axis DNA Labs Description and Major Businesses
 Table 101. Axis DNA Labs Product Features and Attributes
 Table 102. Axis DNA Labs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Axis DNA Labs Recent Developments
 Table 104. AffinityDNA Corporation Information
 Table 105. AffinityDNA Description and Major Businesses
 Table 106. AffinityDNA Product Features and Attributes
 Table 107. AffinityDNA Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. AffinityDNA Recent Developments
 Table 109. Ultrasound Plus Corporation Information
 Table 110. Ultrasound Plus Description and Major Businesses
 Table 111. Ultrasound Plus Product Features and Attributes
 Table 112. Ultrasound Plus Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Ultrasound Plus Recent Developments
 Table 114. PrenatalGeneticslab Corporation Information
 Table 115. PrenatalGeneticslab Description and Major Businesses
 Table 116. PrenatalGeneticslab Product Features and Attributes
 Table 117. PrenatalGeneticslab Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. PrenatalGeneticslab Recent Developments
 Table 119. Acecgt Group Corporation Information
 Table 120. Acecgt Group Description and Major Businesses
 Table 121. Acecgt Group Product Features and Attributes
 Table 122. Acecgt Group Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Acecgt Group Recent Developments
 Table 124. EasyDNA Corporation Information
 Table 125. EasyDNA Description and Major Businesses
 Table 126. EasyDNA Product Features and Attributes
 Table 127. EasyDNA Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. EasyDNA Recent Developments
 Table 129. DNAQ Corporation Information
 Table 130. DNAQ Description and Major Businesses
 Table 131. DNAQ Product Features and Attributes
 Table 132. DNAQ Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. DNAQ Recent Developments
 Table 134. Choice DNA Corporation Information
 Table 135. Choice DNA Description and Major Businesses
 Table 136. Choice DNA Product Features and Attributes
 Table 137. Choice DNA Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Choice DNA Recent Developments
 Table 139. DNA Forensics Laboratory Corporation Information
 Table 140. DNA Forensics Laboratory Description and Major Businesses
 Table 141. DNA Forensics Laboratory Product Features and Attributes
 Table 142. DNA Forensics Laboratory Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. DNA Forensics Laboratory Recent Developments
 Table 144. Brooklyn DNA Testing Corporation Information
 Table 145. Brooklyn DNA Testing Description and Major Businesses
 Table 146. Brooklyn DNA Testing Product Features and Attributes
 Table 147. Brooklyn DNA Testing Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. Brooklyn DNA Testing Recent Developments
 Table 149. SmarTest Labs Corporation Information
 Table 150. SmarTest Labs Description and Major Businesses
 Table 151. SmarTest Labs Product Features and Attributes
 Table 152. SmarTest Labs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 153. SmarTest Labs Recent Developments
 Table 154. Fastest Labs Corporation Information
 Table 155. Fastest Labs Description and Major Businesses
 Table 156. Fastest Labs Product Features and Attributes
 Table 157. Fastest Labs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 158. Fastest Labs Recent Developments
 Table 159. Validity Genetics Corporation Information
 Table 160. Validity Genetics Description and Major Businesses
 Table 161. Validity Genetics Product Features and Attributes
 Table 162. Validity Genetics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 163. Validity Genetics Recent Developments
 Table 164. Suspire LLC Corporation Information
 Table 165. Suspire LLC Description and Major Businesses
 Table 166. Suspire LLC Product Features and Attributes
 Table 167. Suspire LLC Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 168. Suspire LLC Recent Developments
 Table 169. Carlson Company Corporation Information
 Table 170. Carlson Company Description and Major Businesses
 Table 171. Carlson Company Product Features and Attributes
 Table 172. Carlson Company Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 173. Carlson Company Recent Developments
 Table 174. PTC Laboratories Corporation Information
 Table 175. PTC Laboratories Description and Major Businesses
 Table 176. PTC Laboratories Product Features and Attributes
 Table 177. PTC Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 178. PTC Laboratories Recent Developments
 Table 179. My Forever DNA Corporation Information
 Table 180. My Forever DNA Description and Major Businesses
 Table 181. My Forever DNA Product Features and Attributes
 Table 182. My Forever DNA Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 183. My Forever DNA Recent Developments
 Table 184. Dynacare Corporation Information
 Table 185. Dynacare Description and Major Businesses
 Table 186. Dynacare Product Features and Attributes
 Table 187. Dynacare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 188. Dynacare Recent Developments
 Table 189. Vgenes Inc Corporation Information
 Table 190. Vgenes Inc Description and Major Businesses
 Table 191. Vgenes Inc Product Features and Attributes
 Table 192. Vgenes Inc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 193. Vgenes Inc Recent Developments
 Table 194. Raw Materials Key Suppliers
 Table 195. Distributors List
 Table 196. Market Trends and Market Evolution
 Table 197. Market Drivers and Opportunities
 Table 198. Market Challenges, Risks, and Restraints
 Table 199. Research Programs/Design for This Report
 Table 200. Key Data Information from Secondary Sources
 Table 201. Key Data Information from Primary Sources


List of Figures
 Figure 1. Non-invasive Prenatal Paternity Testing(NIPPT) Product Picture
 Figure 2. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Service Product Picture
 Figure 4. Reagents Product Picture
 Figure 5. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Non-legal Paternity Test
 Figure 7. Legal Paternity Test
 Figure 8. Non-invasive Prenatal Paternity Testing(NIPPT) Report Years Considered
 Figure 9. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Region (2020-2031)
 Figure 13. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share Ranking (2024)
 Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 15. Service Revenue Market Share by Player in 2024
 Figure 16. Reagents Revenue Market Share by Player in 2024
 Figure 17. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Type (2020-2031)
 Figure 18. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Application (2020-2031)
 Figure 19. North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY (2020-2031) & (US$ Million)
 Figure 20. North America Top 5 Players Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) in 2024
 Figure 21. North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) by Type (2020 - 2031)
 Figure 22. North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) by Application (2020-2031)
 Figure 23. US Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 24. Canada Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 25. Mexico Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 26. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. Europe Top 5 Players Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) in 2024
 Figure 28. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) by Type (2020-2031)
 Figure 29. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) by Application (2020-2031)
 Figure 30. Germany Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 31. France Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 32. U.K. Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 33. Italy Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 34. Russia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Top 8 Players Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) in 2024
 Figure 37. Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) by Type (2020-2031)
 Figure 38. Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) by Application (2020-2031)
 Figure 39. Indonesia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 40. Japan Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 41. South Korea Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 42. Australia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 43. India Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 44. Indonesia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 45. Vietnam Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 46. Malaysia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 47. Philippines Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 48. Singapore Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2031) & (US$ Million)
 Figure 49. Central and South America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Central and South America Top 5 Players Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) in 2024
 Figure 51. Central and South America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Central and South America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Brazil Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2025) & (US$ Million)
 Figure 54. Argentina Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2025) & (US$ Million)
 Figure 55. Middle East and Africa Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Top 5 Players Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) in 2024
 Figure 57. South America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) by Type (2020-2031)
 Figure 58. Middle East and Africa Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) by Application (2020-2031)
 Figure 59. GCC Countries Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2025) & (US$ Million)
 Figure 60. Israel Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2025) & (US$ Million)
 Figure 61. Egypt Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2025) & (US$ Million)
 Figure 62. South Africa Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2020-2025) & (US$ Million)
 Figure 63. Non-invasive Prenatal Paternity Testing(NIPPT) Industry Chain Mapping
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global NIPT NIPS Testing Service Market Research Report 2024
Global Non invasive Preimplantation Genetic Testing Market Research Report 2024
Global Noninvasive Prenatal Testing Service Market Research Report 2025
Non Invasive Prenatal Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non Invasive Prenatal Testing Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microarray based Non Invasive Prenatal Testing Market Research Report 2024
Global Non Invasive Prenatal Screening NIPS Market Research Report 2024
Global Paternity Test Market Research Report 2025
Global Non Invasive Prenatal DNA Testing Service Market Research Report 2024
Non invasive Prenatal Testing Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non Invasive Prenatal Testing Devices Market Insights Forecast to 2030
Global Non invasive Parenteral Screening Instruments Market Insights Forecast to 2030
Global Non invasive Parenteral Screening Market Insights Forecast to 2030
Global Non Invasive Prenatal Testing NIPT Market Research Report 2024
Global Non Invasive Cancer Detection Market Research Report 2024
Global Blood Relationship Testing Service Market Research Report 2024
Global Prenatal DNA Sequencing Market Size Status and Forecast 2021 2027
Preimplantation genetic testing market
Global Noninvasive Prenatal Gene Testing Technology Market Research Report 2024
Global Prenatal Genetic Screening Test Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions